Ginkgo Bioworks Holdings (Ginkgo Bioworks Holdings) Current Accrued Expense : $108.44 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Ginkgo Bioworks Holdings Current Accrued Expense?

Ginkgo Bioworks Holdings's Current Accrued Expense for the quarter that ended in Mar. 2024 was $108.44 Mil.

Ginkgo Bioworks Holdings's quarterly Current Accrued Expense declined from Sep. 2023 ($114.95 Mil) to Dec. 2023 ($35.05 Mil) but then increased from Dec. 2023 ($35.05 Mil) to Mar. 2024 ($108.44 Mil).

Ginkgo Bioworks Holdings's annual Current Accrued Expense declined from Dec. 2021 ($52.27 Mil) to Dec. 2022 ($32.86 Mil) but then increased from Dec. 2022 ($32.86 Mil) to Dec. 2023 ($35.05 Mil).

Ginkgo Bioworks Holdings Current Accrued Expense Historical Data

The historical data trend for Ginkgo Bioworks Holdings's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ginkgo Bioworks Holdings Current Accrued Expense Chart

Ginkgo Bioworks Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

14.69

52.27

32.86

35.05

Ginkgo Bioworks Holdings Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial											122.62	110.48	114.95	35.05	108.44

Ginkgo Bioworks Holdings Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Ginkgo Bioworks Holdings Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Ginkgo Bioworks Holdings's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Ginkgo Bioworks Holdings (Ginkgo Bioworks Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ginkgo Bioworks Holdings Inc (NYSE:DNA.WS) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

DNA:USA DNA:Mexico

Address

27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210

Website

https://www.ginkgobioworks.com

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Foundry and Biosecurity. The Biosecurity segment generates the majority of revenue.